Correlation Between Nuvation Bio and Inhibrx
Can any of the company-specific risk be diversified away by investing in both Nuvation Bio and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvation Bio and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvation Bio and Inhibrx, you can compare the effects of market volatilities on Nuvation Bio and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvation Bio with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvation Bio and Inhibrx.
Diversification Opportunities for Nuvation Bio and Inhibrx
-0.15 | Correlation Coefficient |
Good diversification
The 3 months correlation between Nuvation and Inhibrx is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Nuvation Bio and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and Nuvation Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvation Bio are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of Nuvation Bio i.e., Nuvation Bio and Inhibrx go up and down completely randomly.
Pair Corralation between Nuvation Bio and Inhibrx
Given the investment horizon of 90 days Nuvation Bio is expected to under-perform the Inhibrx. In addition to that, Nuvation Bio is 1.18 times more volatile than Inhibrx. It trades about -0.12 of its total potential returns per unit of risk. Inhibrx is currently generating about -0.02 per unit of volatility. If you would invest 1,486 in Inhibrx on September 24, 2024 and sell it today you would lose (26.00) from holding Inhibrx or give up 1.75% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Nuvation Bio vs. Inhibrx
Performance |
Timeline |
Nuvation Bio |
Inhibrx |
Nuvation Bio and Inhibrx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Nuvation Bio and Inhibrx
The main advantage of trading using opposite Nuvation Bio and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvation Bio position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.Nuvation Bio vs. Assembly Biosciences | Nuvation Bio vs. Instil Bio | Nuvation Bio vs. Achilles Therapeutics PLC | Nuvation Bio vs. NextCure |
Inhibrx vs. Fate Therapeutics | Inhibrx vs. Sana Biotechnology | Inhibrx vs. Caribou Biosciences | Inhibrx vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
CEOs Directory Screen CEOs from public companies around the world | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |